Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: Patterning, proliferation, and mitochondrial functions of 22q11 genes

International Journal of Developmental Neuroscience

Volumn 29, Issue 3, 2011, Pages 283-294

  Meechan, D W ^a   Maynard, T M ^a   Tucker, E S ^a,b   LaMantia, A S ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

ADHD; Autism; Development; Schizophrenia

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CHROMOSOME 22; CHROMOSOME DELETION 22Q11; COPY NUMBER VARIATION; DIGEORGE SYNDROME; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPITHELIAL MESENCHYMAL TRANSITION; GENE DOSAGE; GENE FUNCTION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HUMAN; MITOCHONDRIAL RESPIRATION; MORPHOGENESIS; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY GATING; SIGNAL TRANSDUCTION; SYNAPTOGENESIS;

22Q11 DELETION SYNDROME; ANIMALS; BRAIN; CELL MOVEMENT; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; GENE DOSAGE; HUMANS; MITOCHONDRIA; MORPHOGENESIS; NEUROGENESIS; PHENOTYPE;

EID: 79953312246     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2010.08.005     Document Type: Article

References (90)

1. Arnsten A.F. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J. Clin. Psychiatry 2006, 67(Suppl. 8):7-12.
2. Bachiller D., Klingensmith J., Shneyder N., Tran U., Anderson R., Rossant J., De Robertis E.M. The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 2003, 130:3567-3578.
3. Bearden C.E., van Erp T.G., Dutton R.A., Tran H., Zimmermann L., Sun D., Geaga J.A., Simon T.J., Glahn D.C., Cannon T.D., Emanuel B.S., Toga A.W., Thompson P.M. Mapping cortical thickness in children with 22q11.2 deletions. Cereb. Cortex 2007, 17:1889-1898.
4. Bearden C.E., van Erp T.G., Dutton R.A., Lee A.D., Simon T.J., Cannon T.D., Emanuel B.S., McDonald-McGinn D., Zackai E.H., Thompson P.M. Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q11.2 deletions. Cereb. Cortex 2009, 19:115-126.
5. Beasley C.L., Zhang Z.J., Patten I., Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol. Psychiatry 2002, 52:708-715.
6. Beites C.L., Campbell K.A., Trimble W.S. The septin Sept5/CDCrel-1 competes with alpha-SNAP for binding to the SNARE complex. Biochem. J. 2005, 385:347-353.
7. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 2000, 31:251-269.
8. Borello U., Cobos I., Long J.E., McWhirter J.R., Murre C., Rubenstein J.L. FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development. Neural Dev. 2008, 3:17.
9. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch. Gen. Psychiatry 1990, 47:181-188.
10. Bussey T.J., Saksida L.M., Rothblat L.A. Discrimination of computer-graphic stimuli by mice: a method for the behavioral characterization of transgenic and gene-knockout models. Behav. Neurosci. 2001, 115:957-960.
11. Carlson C., Sirotkin H., Pandita R., Goldberg R., McKie J., Wadey R., Patanjali S.R., Weissman S.M., Anyane-Yeboa K., Warburton D., Scambler P., Shprintzen R., Kucherlapati R., Morrow B.E. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. Am. J. Hum. Genet. 1997, 61:620-629.
12. Chen W.Y., Shi Y.Y., Zheng Y.L., Zhao X.Z., Zhang G.J., Chen S.Q., Yang P.D., He L. Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum. Mol. Genet. 2004, 13:2991-2995.
13. Cholfin J.A., Rubenstein J.L. Patterning of frontal cortex subdivisions by Fgf17. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7652-7657.
14. Conde F., Lund J.S., Jacobowitz D.M., Baimbridge K.G., Lewis D.A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefontal cortex: distribution and morphology. J. Comp. Neurol. 1994, 341:95-116.
15. Creazzo T.L., Godt R.E., Leatherbury L., Conway S.J., Kirby M.L. Role of cardiac neural crest cells in cardiovascular development. Annu. Rev. Physiol. 1998, 60:267-286.
16. Eliez S., Antonarakis S.E., Morris M.A., Dahoun S.P., Reiss A.L. Parental origin of the deletion 22q11.2 and brain development in velocardiofacial syndrome: a preliminary study. Arch. Gen. Psychiatry 2001, 58:64-68.
17. Faedo A., Borello U., Rubenstein J.L. Repression of Fgf signaling by sprouty1-2 regulates cortical patterning in two distinct regions and times. J. Neurosci. 2010, 30:4015-4023.
18. Frank D.U., Fotheringham L.K., Brewer J.A., Muglia L.J., Tristani-Firouzi M., Capecchi M.R., Moon A.M. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 2002, 129:4591-4603.
19. Garg V., Yamagishi C., Hu T., Kathiriya I.S., Yamagishi H., Srivastava D. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Dev. Biol. 2001, 235:62-73.
20. Geschwind D.H., Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 2007, 17:103-111.
21. Gogos J.A., Santha M., Takacs Z., Beck K.D., Luine V., Lucas L.R., Nadler J.V., Karayiorgou M. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 1999, 21:434-439.
22. Greene C.M., Braet W., Johnson K.A., Bellgrove M.A. Imaging the genetics of executive function. Biol. Psychol. 2008, 79:30-42.
23. Guarguaglini G., Battistoni A., Pittoggi C., Di Matteo G., Di Fiore B., Lavia P. Expression of the murine RanBP1 and Htf9-c genes is regulated from a shared bidirectional promoter during cell cycle progression. Biochem. J. 1997, 325(Pt 1):277-286.
24. Guo W., Wong S., Xie W., Lei T., Luo Z. Palmitate modulates intracellular signaling, induces endoplasmic reticulum stress, and causes apoptosis in mouse 3T3-L1 and rat primary preadipocytes. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E576-586.
25. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefonta; cortex of subjects with schizophrenia. J. Neurosci. 2003, 23:6315-6326.
26. Huang K., Sanders S., Singaraja R., Orban P., Cijsouw T., Arstikaitis P., Yanai A., Hayden M.R., El-Husseini A. Neuronal palmitoyl acyl transferases exhibit distinct substrate specificity. FASEB J. 2009, 23:2605-2615.
27. Huttenlocher P.R. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res. 1979, 163:195-205.
28. Iwanaga T., Tsutsumi R., Noritake J., Fukata Y., Fukata M. Dynamic protein palmitoylation in cellular signaling. Prog. Lipid Res. 2009, 48:117-127.
29. Johnson E.S., Ma P.C., Ota I.M., Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 1995, 270:17442-17456.
30. Kang W., Wong L.C., Shi S.H., Hebert J.M. The transition from radial glial to intermediate progenitor cell is inhibited by FGF signaling during corticogenesis. J. Neurosci. 2009, 29:14571-14580.
31. Kazama H., Ichikawa A., Kohsaka H., Morimoto-Tanifuji T., Nose A. Innervation and activity dependent dynamics of postsynaptic oxidative metabolism. Neuroscience 2008, 152:40-49.
32. Kempf L., Nicodemus K.K., Kolachana B., Vakkalanka R., Verchinski B.A., Egan M.F., Straub R.E., Mattay V.A., Callicott J.H., Weinberger D.R., Meyer-Lindenberg A. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. PLoS Genet. 2008, 4:e1000252.
33. Kiehl T.R., Chow E.W., Mikulis D.J., George S.R., Bassett A.S. Neuropathologic features in adults with 22q11.2 deletion syndrome. Cereb. Cortex 2009, 19:153-164.
34. Kisvarday Z.F. GABAergic networks of basket cells in the visual cortex. Prog. Brain Res. 1992, 90:385-405.
35. LaMantia A.S. Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice. Biol. Psychiatry 1999, 46:19-30.
36. Leana-Cox J., Pangkanon S., Eanet K.R., Curtin M.S., Wulfsberg E.A. Familial DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2: report of five families with a review of the literature. Am. J. Med. Genet. 1996, 65:309-316.
37. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005, 6:312-324.
38. Lindsay E.A., Vitelli F., Su H., Morishima M., Huynh T., Pramparo T., Jurecic V., Ogunrinhu G., Sutherland H.F., Scambler P.J., Bradley A., Baldini A. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 2001, 410:97-101.
39. Liu H., Abecasis G.R., Heath S.C., Knowles A., Demars S., Chen Y.J., Roos J.L., Rapoport J.L., Gogos J.A., Karayiorgou M. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16859-16864.
40. Lobo S., Greentree W.K., Linder M.E., Deschenes R.J. Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J. Biol. Chem. 2002, 277:41268-41273.
41. Long J.M., Laporte P., Merscher S., Funke B., Saint-Jore B., Puech A., Kucherlapati R., Morrow B.E., Skoultchi A.I., Wynshaw-Boris A. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 2006, 7:247-257.
42. Mao Y., Ge X., Frank C.L., Madison J.M., Koehler A.N., Doud M.K., Tassa C., Berry E.M., Soda T., Singh K.K., Biechele T., Petryshen T.L., Moon R.T., Haggarty S.J., Tsai L.H. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009, 136:1017-1031.
43. Maynard T.M., Haskell G.T., Bhasin N., Lee J.M., Gassman A.A., Lieberman J.A., LaMantia A.S. RanBP1, a velocardiofacial/DiGeorge syndrome candidate gene, is expressed at sites of mesenchymal/epithelial induction. Mech. Dev. 2002, 111:177-180.
44. Maynard T.M., Haskell G.T., Peters A.Z., Sikich L., Lieberman J.A., LaMantia A.S. A comprehensive analysis of 22q11 gene expression in the developing and adult brain. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14433-14438.
45. Maynard T.M., Meechan D.W., Heindel C.C., Peters A.Z., Hamer R.M., Lieberman J.A., LaMantia A.S. No evidence for parental imprinting of mouse 22q11 gene orthologs. Mamm. Genome 2006, 17:822-832.
46. Maynard T.M., Meechan D.W., Dudevoir M.L., Gopalakrishna D., Peters A.Z., Heindel C.C., Sugimoto T.J., Wu Y., Lieberman J.A., Lamantia A.S. Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes. Mol. Cell. Neurosci. 2008, 39:439-451.
47. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch. Gen. Psychiatry 2000, 57:637-648.
48. Meechan D.W., Maynard T.M., Wu Y., Gopalakrishna D., Lieberman J.A., LaMantia A.S. Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. Mol. Cell. Neurosci. 2006, 33:412-428.
49. Meechan D.W., Tucker E.S., Maynard T.M., LaMantia A.S. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:16434-16445.
50. Merscher S., Funke B., Epstein J.A., Heyer J., Puech A., Lu M.M., Xavier R.J., Demay M.B., Russell R.G., Factor S., Tokooya K., Jore B.S., Lopez M., Pandita R.K., Lia M., Carrion D., Xu H., Schorle H., Kobler J.B., Scambler P., Wynshaw-Boris A., Skoultchi A.I., Morrow B.E., Kucherlapati R. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 2001, 104:619-629.
51. Minshew N.J., Williams D.L. The new neurobiology of autism: cortex, connectivity, and neuronal organization. Arch. Neurol. 2007, 64:945-950.
52. Morison I.M., Ramsay J.P., Spencer H.G. A census of mammalian imprinting. Trends. Genet. 2005, 21:457-465.
53. Moyer S.E., Lewis P.W., Botchan M.R. Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10236-10241.
54. Mukai J., Liu H., Burt R.A., Swor D.E., Lai W.S., Karayiorgou M., Gogos J.A. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 2004, 36:725-731.
55. Mukai J., Dhilla A., Drew L.J., Stark K.L., Cao L., MacDermott A.B., Karayiorgou M., Gogos J.A. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 2008, 11:1302-1310.
56. Murphy K.C., Jones L.A., Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 1999, 56:940-945.
57. Nakai A., Taniuchi Y., Asakura H., Oya A., Yokota A., Koshino T., Araki T. Developmental changes in mitochondrial activity and energy metabolism in fetal and neonatal rat brain. Brain Res. Dev. Brain Res. 2000, 121:67-72.
58. Niklasson L., Rasmussen P., Oskarsdottir S., Gillberg C., Austism A.D.H.D. Mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res. Dev. Disabil. 2008, 31:185-194.
59. Noctor S.C., Martinez-Cerdeno V., Ivic L., Kriegstein A.R. Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases. Nat. Neurosci. 2004, 7:136-144.
60. Paulsen M., Takada S., Youngson N.A., Benchaib M., Charlier C., Segers K., Georges M., Ferguson-Smith A.C. Comparative sequence analysis of the imprinted Dlk1-Gtl2 locus in three mammalian species reveals highly conserved genomic elements and refines comparison with the Igf2-H19 region. Genome Res. 2001, 11:2085-2094.
61. Paylor R., Glaser B., Mupo A., Ataliotis P., Spencer C., Sobotka A., Sparks C., Choi C.H., Oghalai J., Curran S., Murphy K.C., Monks S., Williams N., O'Donovan M.C., Owen M.J., Scambler P.J., Lindsay E. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7729-7734.
62. Peng X.R., Jia Z., Zhang Y., Ware J., Trimble W.S. The septin CDCrel-1 is dispensable for normal development and neurotransmitter release. Mol. Cell Biol. 2002, 22:378-387.
63. Peterson J.M., Wang Y., Bryner R.W., Williamson D.L., Alway S.E. Bax signaling regulates palmitate-mediated apoptosis in C(2)C(12) myotubes. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1307-1314.
64. Phang J.M., Downing S.J., Yeh G.C. Linkage of the HMP pathway to ATP generation by the proline cycle. Biochem. Biophys. Res. Commun. 1980, 93:462-470.
65. Rakic P., Bourgeois J.P., Eckenhoff M.F., Zecevic N., Goldman-Rakic P.S. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science 1986, 232:232-235.
66. Ryan A.K., Goodship J.A., Wilson D.I., Philip N., Levy A., Seidel H., Schuffenhauer S., Oechsler H., Belohradsky B., Prieur M., Aurias A., Raymond F.L., Clayton-Smith J., Hatchwell E., McKeown C., Beemer F.A., Dallapiccola B., Novelli G., Hurst J.A., Ignatius J., Green A.J., Winter R.M., Brueton L., Brondum-Nielsen K., Scambler P.J., et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 1997, 34:798-804.
67. Sahara S., O'Leary D.D. Fgf10 regulates transition period of cortical stem cell differentiation to radial glia controlling generation of neurons and basal progenitors. Neuron 2009, 63:48-62.
68. Sakai D., Suzuki T., Osumi N., Wakamatsu Y. Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development 2006, 133:1323-1333.
69. Samuels I.S., Karlo J.C., Faruzzi A.N., Pickering K., Herrup K., Sweatt J.D., Saitta S.C., Landreth G.E. Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function. J. Neurosci. 2008, 28:6983-6995.
70. Schaer M., Schmitt J.E., Glaser B., Lazeyras F., Delavelle J., Eliez S. Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study. Psychiatry Res. 2006, 146:1-11.
71. Sefton M., Sanchez S., Nieto M.A. Conserved and divergent roles for members of the Snail family of transcription factors in the chick and mouse embryo. Development 1998, 125:3111-3121.
72. Shprintzen R.J., Higgins A.M., Antshel K., Fremont W., Roizen N., Kates W. Velo-cardio-facial syndrome. Curr. Opin. Pediatr. 2005, 17:725-730.
73. Sigurdsson T., Stark K.L., Karayiorgou M., Gogos J.A., Gordon J.A. Impaired hippocampal-prefontal synchrony in a genetic mouse model of schizophrenia. Nature 2010, 464:763-767.
74. Son J.H., Kawamata H., Yoo M.S., Kim D.J., Lee Y.K., Kim S., Dawson T.M., Zhang H., Sulzer D., Yang L., Beal M.F., Degiorgio L.A., Chun H.S., Baker H., Peng C. Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons. J. Neurochem. 2005, 94:1040-1053.
75. Stark K.L., Xu B., Bagchi A., Lai W.S., Liu H., Hsu R., Wan X., Pavlidis P., Mills A.A., Karayiorgou M., Gogos J.A. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 2008, 40:751-760.
76. Storm E.E., Garel S., Borello U., Hebert J.M., Martinez S., McConnell S.K., Martin G.R., Rubenstein J.L. Dose-dependent functions of Fgf8 in regulating telencephalic patterning centers. Development 2006, 133:1831-1844.
77. Sudo H., Tsuji A.B., Sugyo A., Imai T., Saga T., Harada Y.N. A loss of function screen identifies nine new radiation susceptibility genes. Biochem. Biophys. Res. Commun. 2007, 364:695-701.
78. Suzuki G., Harper K.M., Hiramoto T., Sawamura T., Lee M., Kang G., Tanigaki K., Buell M., Geyer M.A., Trimble W.S., Agatsuma S., Hiroi N. Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice. Hum. Mol. Genet. 2009, 18:1652-1660.
79. Swarthout J.T., Lobo S., Farh L., Croke M.R., Greentree W.K., Deschenes R.J., Linder M.E. DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras. J. Biol. Chem. 2005, 280:31141-31148.
80. Tamamaki N., Yanagawa Y., Tomioka R., Miyazaki J., Obata K., Kaneko T. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J. Comp. Neurol. 2003, 467:60-79.
81. Tedeschi A., Ciciarello M., Mangiacasale R., Roscioli E., Rensen W.M., Lavia P. RANBP1 localizes a subset of mitotic regulatory factors on spindle microtubules and regulates chromosome segregation in human cells. J. Cell. Sci. 2007, 120:3748-3761.
82. Tickle C., Eichele G. Vertebrate limb development. Annu. Rev. Cell. Biol. 1994, 10:121-152.
83. Tucker E.S., Segall S., Gopalakrishna D., Wu Y., Vernon M., Polleux F., Lamantia A.S. Molecular specification and patterning of progenitor cells in the lateral and medial ganglionic eminences. J. Neurosci. 2008, 28:9504-9518.
84. Turpin S.M., Lancaster G.I., Darby I., Febbraio M.A., Watt M.J. Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E1341-E1350.
85. van Amelsvoort T., Daly E., Henry J., Robertson D., Ng V., Owen M., Murphy K.C., Murphy D.G. Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. Arch. Gen. Psychiatry 2004, 61:1085-1096.
86. Vermot J., Niederreither K., Garnier J.M., Chambon P., Dolle P. Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice. Proc. Natl. Acad. Sci U.S.A. 2003, 100:1763-1768.
87. Washington Smoak I., Byrd N.A., Abu-Issa R., Goddeeris M.M., Anderson R., Morris J., Yamamura K., Klingensmith J., Meyers E.N. Sonic hedgehog is required for cardiac outflow tract and neural crest cell development. Dev. Biol. 2005, 283:357-372.
88. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
89. Weinberger D.R. On the plausibility of " the neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology 1996, 14:1S-11S.
90. Zhao L., Lobo S., Dong X., Ault A.D., Deschenes R.J. Erf4p and Erf2p form an endoplasmic reticulum-associated complex involved in the plasma membrane localization of yeast Ras proteins. J. Biol. Chem. 2002, 277:49352-49359.